Stockholders' Equity (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019
Capital stock shares authorized	100,000,000
Common stock shares authorized	90,000,000	90,000,000
Common stock par value	$ 0.000001	$ 0.000001
Preferred stock shares authorized	10,000,000	10,000,000
Preferred stock par value	$ 0.000001	$ 0.000001
Proceeds from common stock sold	$ 275,000	$ 10,500,000
Number of shares issued during period, value	275,000
Loss on the settlement of debt		252,900
Weighted-average fair value of options	$ 0.211
Weighted-average exercise price of options
Stock option expense	$ 739,973
Unamortized stock option expense	$ 253,830
Minimum [Member]
Weighted-average fair value of options	$ 1.11
Weighted-average exercise price of options	$ 4.00
Initial Public Offering [Member]
Number of shares issued during period, shares		2,625,000
Sale of stock, price per share		$ 4.00
Proceeds from issuance of public offering		$ 10,500,000
Number of warrants outstanding	131,250
Exercise price outstanding	$ 5.00
Warrant expire date	Nov. 30, 2024
Three Investors [Member]
Common stock sold	2,553,571
Proceeds from common stock sold	$ 275,000
Board of Director [Member]
Common stock sold	125,000
Proceeds from common stock sold	$ 25,000
Vendors [Member]
Number of shares issued during period, shares		84,300
Accounts payable and accrued expenses		$ 421,500
Number of shares issued during period, value		$ 674,000